Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | ME22S |
Synonyms | |
Therapy Description |
ME22S is a bispecific antibody that targets EGFR and MET, which results in decreased tumor cell proliferation and migration (PMID: 26812910). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ME22S | EGFR Antibody 56 MET Antibody 28 | ME22S is a bispecific antibody that targets EGFR and MET, which results in decreased tumor cell proliferation and migration (PMID: 26812910). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|